4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-049620
Chief Tech. Operations Officer sold 1,500 shares at an average $39.45 ($59,178)
- Chief Tech. Operations Officer acquired 1,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Newell Joe · Chief Tech. Operations Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-09-04 | Exercise or conversion : show line 1 in the form | +1,500 | $20.40 | $30,600 | 33,358 | D |
| 2018-09-04 | Sale : show line 2 in the form | −1,002 | $39.16 | $39,238 | 32,356 | D |
| 2018-09-04 | Sale : show line 3 in the form | −498 | $40.04 | $19,940 | 31,858 | D |
| Open-market sales · 1,500 sh · avg $39.45 · $59,178 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-09-04 | Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) | −1,500 | 77,000 | D |
Loading xslF345X03/doc4.xml…